Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19801574rdf:typepubmed:Citationlld:pubmed
pubmed-article:19801574lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C0018802lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C0003591lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:19801574lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:19801574pubmed:issue11lld:pubmed
pubmed-article:19801574pubmed:dateCreated2009-10-30lld:pubmed
pubmed-article:19801574pubmed:abstractTextFew studies have analysed the influence of lipoprotein components (LC) on the development of congestive heart failure (HF) in large healthy populations. We examined LC together with glucose, haptoglobin (Hp), and uric acid (UA) as risk factors for HF in the Apolipoprotein MOrtality RISk (AMORIS) study. We also explored the possible interaction between these factors and the apolipoprotein B to apolipoprotein A-1 ratio (apoB/apoA-1) in HF.lld:pubmed
pubmed-article:19801574pubmed:languageenglld:pubmed
pubmed-article:19801574pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:citationSubsetIMlld:pubmed
pubmed-article:19801574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19801574pubmed:statusMEDLINElld:pubmed
pubmed-article:19801574pubmed:monthNovlld:pubmed
pubmed-article:19801574pubmed:issn1879-0844lld:pubmed
pubmed-article:19801574pubmed:authorpubmed-author:HammarNiklasNlld:pubmed
pubmed-article:19801574pubmed:authorpubmed-author:AastveitAre...lld:pubmed
pubmed-article:19801574pubmed:authorpubmed-author:HolmeIngarIlld:pubmed
pubmed-article:19801574pubmed:authorpubmed-author:WalldiusGöran...lld:pubmed
pubmed-article:19801574pubmed:authorpubmed-author:JungnerIngmar...lld:pubmed
pubmed-article:19801574pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19801574pubmed:volume11lld:pubmed
pubmed-article:19801574pubmed:ownerNLMlld:pubmed
pubmed-article:19801574pubmed:authorsCompleteYlld:pubmed
pubmed-article:19801574pubmed:pagination1036-42lld:pubmed
pubmed-article:19801574pubmed:dateRevised2011-6-8lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:meshHeadingpubmed-meshheading:19801574...lld:pubmed
pubmed-article:19801574pubmed:year2009lld:pubmed
pubmed-article:19801574pubmed:articleTitleLipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).lld:pubmed
pubmed-article:19801574pubmed:affiliationDepartment of Preventive Cardiology, Centre of Preventive Medicine, Oslo University Hospital, Ulleval, Oslo N-0407, Norway. ingar.holme@uus.nolld:pubmed
pubmed-article:19801574pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19801574pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19801574pubmed:publicationTypeMulticenter Studylld:pubmed